SHE:300436 Revenue

Fujian Cosunter Pharmaceutical had revenue of 97.61M CNY in the quarter ending March 31, 2025, a decrease of -18.69%. This brings the company's revenue in the last twelve months to 419.02M, down -7.81% year-over-year. In the year 2024, Fujian Cosunter Pharmaceutical had annual revenue of 441.46M with 4.43% growth.

Revenue (ttm)

419.02M

Revenue Growth

-7.81%

P/S Ratio

55.34

Revenue / Employee

551.34K

Employees

760

Market Cap

23.19B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	441.46M	18.74M	4.43%
Dec 31, 2023	422.71M	36.95M	9.58%
Dec 31, 2022	385.77M	15.32M	4.14%
Jan 1, 2022	370.44M	1.95M	0.53%
Dec 31, 2020	368.49M	-46.38M	-11.18%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
WuXi AppTec	41.48B
Shenzhen Mindray Bio-Medical Electronics	35.59B
Sichuan Biokin Pharmaceutical	5.82B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings